Poland· PL-100329381
Linezolid Kabi
A linezolid product containing linezolidum, registered in Poland by Fresenius Kabi Polska Sp. z o.o.. The same ATC class is registered in 19 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Linezolid is registered in 19 of 19 countries.
Countries holding a registration under ATC J01XX08 (linezolid), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 11 of them publish a price we can compare per daily dose
Linezolid · ATC J01XX08
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of linezolid costs, country by country.
Normalised to the WHO defined daily dose (1.2 g), so markets compare like for like.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Linezolid · price per daily dose (1.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$125.76
- IT Italy$109.29
The record
At a glance
URPL (Poland)- Active substance
- Linezolidum
- Manufacturer
- Fresenius Kabi Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- J01XX08
- ATC class
- Linezolid
- Defined daily dose
- 1.2 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 6
- gtin05909991243050
- gtin05909991216467
- gtin05909991216474
- gtin05909991216481
- gtin05909991243036
- gtin05909991243043
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
393 interactions on record for linezolid.
Graded by severity as the source publishes them — 69 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Linezolid · interactions on record
393 records
- 69 severe
- 196 moderate
- 116 info
Most severe, free to view
- IsomethepteneA03AX10severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
12 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Linezolid in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesLinezolidSandoz Inc
- CzechiaLINEZOLID DEMODEMO S.A. Pharmaceutical Industry, Krioneri, Attiki
- SpainLINEZOLID ACCORDPHARMA 2 mg/ml SOLUCIÓN PARA PERFUSION EFGAccord Healthcare S.L.U.
- BelgiumLinezolid Accord 2 mg/mlAccord Healthcare
- FinlandLinezolid AccordAccord Healthcare B.V.
- SwedenLinezolid Accord 2 mg/ml Infusionsvätska, lösningAccord Healthcare B.V.
- IrelandLinezolid 2 mg/ml solution for infusionFresenius Kabi Deutschland GmbH
- SwitzerlandLinezolid Pfizer 2 mg/mI, lnfusionslösungPfizer AG
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Ilenozyd, Linezolid 1a Pharma
- Belgium · Linezolid Fresenius Kabi, Linezolid Sandoz
- Bulgaria · Linezolid Kabi, Линезолид Крка
- Cyprus · Apel, Linezid
- Czechia · Linezolid Accord, Linezolid Demo
- Germany · Linezolid 1 A Pharma, Linezolid Accord
- Denmark · Linezolid "sandoz", Linezolid Accord
- Estonia · Apel, Linezolid Accord
- Spain · Apel, Linezolid Accordpharma
- Finland · Linezolid Accord, Linezolid Krka
- France · Linezolide Accord, Linezolide Arrow
- United Kingdom (Northern Ireland) · Linezolid, Linezolid Accord Healthcare
- Greece · Antizolid, Linesol
- Croatia · Linezolid Kabi, Linezolid Krka
- Hungary · Anozilad, Linesan
- Ireland · Linezolid, Linezolid Accord Healthcare Ireland
- Iceland · Zyvoxid
- Italy · Linezolid Aurobindo, Linezolid Aurobindo Italia
- Lithuania · Disenil, Linezolid Accord
- Luxembourg · Linezolid Dr. Eberth, Linezolid Fresenius Kabi
- Latvia · Apel, Linezolid Accord
- Malta · Apel, Zyvox
- Netherlands · Dilizolen, Linezolid Accord
- Norway · Linezolid Accord, Linezolid Fresenius Kabi
- Portugal · Linezolida Accord, Linezolida Accordpharma
- Romania · Linezolid, Linezolid Aurobindo
- Sweden · Linezolid Accord, Linezolid Glenmark
- Slovenia · Linezolid Accord, Linezolid Kabi
- Slovakia · Apel, Linezolid Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f4e1127f-0ded-4b10-a382-fd28c0b520d3 GET /v1/drugs/f4e1127f-0ded-4b10-a382-fd28c0b520d3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do infuzji",
"source": "urpl",
"strength": "2 mg/ml",
"packaging": "05909991216467 ¦ Lz ¦ 107805\n10 worków po 300 ml\n05909991216474 ¦ Lz ¦ 107806\n30 worków po 300 ml\n05909991216481 ¦ Lz ¦ 107807\n50 worków po 300 ml\n05909991243036 ¦ Lz ¦ 111603\n10 butelek po 300 ml\n05909991243043 ¦ Lz ¦ 111604\n30 butelek po 300 ml\n05909991243050 ¦ Lz ¦ 111605\n50 butelek po 300 ml",
"substance": "Linezolidum 2 mg/ml",
"common_name": "Linezolidum",
"pl_product_id": "100329381",
"pozwolenie_nr": "22370",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about linezolid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.